HCmed Innovations Co., Ltd. (TPE:6934)
Taiwan · Delayed Price · Currency is TWD 71.90
-0.70 (-0.96%)
At close: Jun 2, 2026
HCmed Innovations Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -126.11 | -78.21 | -165.93 | -143.79 | -40.19 |
Depreciation & Amortization | 22.72 | 23.78 | 23.06 | 13.93 | 8.84 |
Other Amortization | 0.49 | 0.32 | 0.15 | 0.17 | 0.2 |
Asset Writedown & Restructuring Costs | 11.86 | 17.07 | 23.33 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | -1.63 | - |
Loss (Gain) on Equity Investments | - | - | - | 0.19 | 1.57 |
Stock-Based Compensation | 23.72 | 9.89 | - | 41.73 | 13.64 |
Provision & Write-off of Bad Debts | 0.04 | -0.01 | 0.01 | - | - |
Other Operating Activities | -2.89 | -1.65 | -0.49 | -0.24 | -0 |
Change in Accounts Receivable | -4.94 | -1.18 | 0.08 | -0.28 | 4.92 |
Change in Inventory | -8.09 | 0.35 | -0.52 | 6.09 | 1.68 |
Change in Accounts Payable | 5.68 | 0.53 | -0.52 | 1.24 | -0.62 |
Change in Unearned Revenue | -0.95 | -8.06 | 9.01 | - | -11.95 |
Change in Other Net Operating Assets | 12.37 | 4.65 | 0.21 | 2.18 | 2.08 |
Operating Cash Flow | -66.13 | -32.54 | -111.61 | -80.4 | -19.82 |
Capital Expenditures | -58.07 | -10.84 | -16.12 | -7.55 | - |
Cash Acquisitions | - | - | - | 0.05 | - |
Sale (Purchase) of Intangibles | - | -0.55 | -0.26 | -0.41 | - |
Sale (Purchase) of Real Estate | - | -11.34 | - | - | -5.32 |
Investment in Securities | -15 | 67 | -177 | - | -6.8 |
Other Investing Activities | -1.45 | 0.18 | -1.77 | -0.2 | -0.37 |
Investing Cash Flow | -74.53 | 44.45 | -195.15 | -8.12 | -12.5 |
Long-Term Debt Issued | 45.8 | - | - | - | - |
Long-Term Debt Repaid | -12.94 | -13.33 | -12.09 | -6.28 | -5.14 |
Net Debt Issued (Repaid) | 32.86 | -13.33 | -12.09 | -6.28 | -5.14 |
Issuance of Common Stock | 180.51 | 0.23 | 262.14 | 169.8 | - |
Financing Cash Flow | 213.37 | -13.1 | 250.05 | 163.52 | -5.14 |
Foreign Exchange Rate Adjustments | 0.01 | 0.4 | -0.17 | - | - |
Net Cash Flow | 72.72 | -0.79 | -56.88 | 75.01 | -37.46 |
Free Cash Flow | -124.2 | -43.38 | -127.74 | -87.95 | -19.82 |
Free Cash Flow Margin | -123.91% | -30.63% | -1383.17% | -1357.64% | -36.67% |
Free Cash Flow Per Share | -3.86 | -1.44 | -4.81 | -4.07 | -1.13 |
Cash Interest Paid | 1.53 | 0.24 | 0.29 | 0.06 | 0.05 |
Cash Income Tax Paid | 0.25 | 28.94 | 0.02 | - | - |
Levered Free Cash Flow | -83.61 | -4.41 | -74.37 | -35.65 | 5.6 |
Unlevered Free Cash Flow | -82.66 | -4.26 | -74.19 | -35.61 | 5.64 |
Change in Working Capital | 4.06 | -3.71 | 8.26 | 9.23 | -3.89 |